|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.85 EUR | -2.07% |
|
-3.30% | -17.56% |
| May. 08 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | Pharming Group N.V. Provides Revenue Guidance for 2024 | CI |
Pharming Group N.V. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 42.54 million compared to USD 46.62 million a year ago. Net loss was USD 12.21 million compared to net income of USD 3.46 million a year ago.
Basic loss per share from continuing operations was USD 0.019 compared to basic earnings per share from continuing operations of USD 0.005 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.56% | 632M | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
PHARMING GROUP N.V. 